Singapur - angličtina - HSA (Health Sciences Authority)

quantum technologies global pte. ltd. - sodium iodide na131i, solution - capsule - sodium iodide na131i, solution 37-5500 mbq

Spojené státy - angličtina - NLM (National Library of Medicine)

mallinckrodt nuclear medicine llc - sodium iodide i-131 (unii: 29vco8achh) (iodide ion i-131 - unii:4gc1foq22u) - iodide ion i-131 1 mci in 1 ml

Izrael - angličtina - Ministry of Health

eldan electronic instruments co ltd, israel - sodium iodide (131 i) - hard capsule - sodium iodide (131 i) 37 - 5550 mbq - sodium iodide (131i) - sodium iodide (131i) - theracap 131 is a radioiodine thyroid therapy indicated for:1.treatment of grave's disease, toxic multinodular goitre or autonomous nodules.2.treatmernt of papilary and follicular thyroid carcinoma including metastastic desease.

Kanada - angličtina - Health Canada

jubilant draximage inc. dba jubilant radiopharma - sodium iodide 131 i - capsule - 7400mbq - sodium iodide 131 i 7400mbq - radioactive agents

Kanada - angličtina - Health Canada

jubilant draximage inc. dba jubilant radiopharma - sodium iodide 131 i - solution - 7400mbq - sodium iodide 131 i 7400mbq - radioactive agents

Spojené státy - angličtina - NLM (National Library of Medicine)

jubilant draximage inc., dba jubilant radiopharma - sodium iodide i-131 (unii: 29vco8achh) (iodide ion i-131 - unii:4gc1foq22u) - iodide ion i-131 1 mci in 1 ml - hicon® is indicated for the treatment of hyperthyroidism and selected cases of thyroid carcinoma. hicon® is contraindicated in: - patients with vomiting and diarrhea [see warnings and precautions (5.7)] . - patients with thyroid malignancies shown to have no iodide uptake, which include the majority of medullary or anaplastic carcinomas. - patients receiving concurrent anti-thyroid therapy [see warnings and precautions (5.1) and drug interactions (7)] . - pregnancy [see warnings and precautions (5.4), use in specific populations (8.1)] . - lactation [see warnings and precautions (5.5), use in specific populations (8.2)] . risk summary hicon® is contraindicated in pregnancy because fetal exposure can lead to neonatal hypothyroidism, which in some cases is severe and irreversible [see warnings and precautions (5.4)] . data from the published literature describe reports of neonatal thyroid abnormalities after fetal exposure; including agenesis of the thyroid and hypothyroidism (see clinical considerations

Spojené státy - angličtina - NLM (National Library of Medicine)

app pharmaceuticals, llc - sodium iodide (unii: f5wr8n145c) (iodide ion - unii:09g4i6v86q) - sodium iodide 118 ug in 1 ml

Filipíny - angličtina - FDA (Food And Drug Administration)

vista pharma inc - potassium iodide , sodium iodide - solution, ophthalmic - 3mg+3mg per ml

Spojené státy - angličtina - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 234 mg in 1 ml - sodium chloride injection, usp, 23.4%, is indicated as an additive in parenteral fluid therapy for use in patients who have special problems of sodium electrolyte intake or excretion.  it is intended to meet the specific requirements of the patient with unusual fluid and electrolyte needs.  after available clinical and laboratory information is considered and correlated, the appropriate number of milliequivalents of sodium chloride required can be withdrawn from sodium chloride injection, usp, 23.4% and diluted for use. sodium chloride injection is indicated for the treatment of sodium, chloride and water deficiencies that commonly occur in many diseases.  isotonic sodium chloride injection should be limited to cases in which the chloride loss is greater than the sodium loss, as in vomiting from pyloric obstruction, or in which the loss is about equal, as in vomiting from duodenal, jejunal or ileal obstruction and in the replacement of aspirated gastrointestinal fluids. the toxic symptoms that follow various

Spojené státy - angličtina - NLM (National Library of Medicine)

general injectables & vaccines, inc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 234 mg in 30 ml - sodium chloride injection, usp, 23.4%, is indicated as an additive in parenteral fluid therapy for use in patents who have special problems of sodium electrolyte intake or excretion. it is intended to meet the specific requirements of the patient with unusual fluid and electrolyte needs. after available clinical and laboratory information is considered and correlated, the appropriate number of milliequivalents of sodium chloride required can be withdrawn from sodium chloride injection, usp, 23.4% and diluted for use. sodium chloride injection is indicated for the treatment of sodium, chloride and water deficiencies that commonly occur in many diseases. isotonic sodium chloride injection should be limited to cases in which the chloride loss is greater than the sodium loss, as in vomiting from pyloric obstruction, or in which the loss is about equal, as in vomiting from duodenal, jejunal or ileal obstruction and in the replacement of aspirated gastrointestinal fluids. the toxic symptoms that follow various form